By Jana Wu, LCSW, LADC, ICAADC, CASAC
For more than 15 years, I have worked on the front lines of mental health and substance use treatment. As I approach my 50th birthday, I find myself circling back to a question that is as much a professional critique as it is a personal observation: Why is the medical establishment so reflexively quick to relieve women’s distress before we have taken the time to fully understand its source?
In recent years, the rise of kratom—a tropical tree leaf from Southeast Asia that produces opioid-like and stimulant-like effects—has brought this question into sharp, often uncomfortable focus. I have sat across from countless women, ranging from their late 30s to their 60s, who stumbled upon kratom while desperately searching for a salve for anxiety, chronic pain, or crippling fatigue.
They do not describe kratom as a recreational pursuit. They describe it as a survival strategy—a tool to keep functioning in lives that have become physically and emotionally unsustainable. They report using it to manage the “second shift”: working full-time jobs, keeping up with children, caring for aging parents, and meeting the relentless, often impossible demands of modern womanhood. But in our haste to provide a chemical fix for these symptoms, we may be repeating a dark historical cycle.
A Century of "Little Helpers": The Chronology of Medicalized Distress
The tendency to suppress women’s discomfort with medication is not a modern phenomenon. To understand the current landscape of kratom use, we must look at the historical trajectory of how we have treated the "anxious woman."
The Victorian Era: Hysteria and Neurasthenia
In the 19th century, the medical community frequently pathologized women’s stress under the umbrellas of "hysteria" and "neurasthenia." These diagnoses were catch-alls for anything from insomnia and irritability to chronic pain and fatigue. Rather than questioning the social structures that relegated women to confined domestic roles, physicians prescribed bed rest, tonics, and sedatives.
The Mid-20th Century: The Tranquilizer Revolution
By the mid-1900s, the approach had shifted from tonics to synthetic pharmacology. Miltown, the first mass-marketed tranquilizer, became a household name. This paved the way for the arrival of Valium in 1963. Within years, Valium became the most prescribed medication in the United States. Its ubiquity was such that it became a cultural shorthand for the suburban housewife’s survival kit.
The 1966 Rolling Stones anthem "Mother’s Little Helper" captured this zeitgeist perfectly: a woman relying on "yellow pills" to survive the pressures of family life, domestic chores, and the encroaching anxiety of aging. Nearly 60 years later, the lyrics remain chillingly relevant. While the names of the drugs have evolved from Valium to Xanax to the current, unregulated frontier of kratom, the underlying narrative of the "overburdened woman seeking relief" remains static.
Supporting Data: The Midlife Pressure Cooker
The current surge in kratom use among middle-aged women cannot be divorced from the biological and social realities of midlife. This is a demographic uniquely susceptible to systemic failure.
The Biological "Perfect Storm"
Perimenopause often acts as a catalyst for profound physiological changes. Hormonal fluctuations can trigger the sudden onset of severe anxiety, insomnia, and mood dysregulation. For many women, these symptoms appear for the first time in their 40s or 50s, leading them to seek medical intervention.
The Societal Load
Simultaneously, these women are often part of the "sandwich generation," managing the professional expectations of their peak earning years while navigating the caretaking responsibilities of both children and aging parents. When they present these issues to healthcare providers, the current system is frequently better equipped to quiet the symptom—through a prescription or a quick-fix supplement—than to investigate the environment causing the distress.
We are effectively treating the manifestation of burnout as if it were a primary, standalone psychiatric disorder, ignoring the "life surrounding the symptom."
The Kratom Conundrum: Natural vs. Risk-Free
Kratom has emerged as a distinct player in this landscape. For many, it represents an attempt to bypass a pharmaceutical system that they feel has either failed them or labeled them too quickly. By choosing something they perceive as "natural" or "traditional," women feel they are reclaiming agency over their own bodies.
However, the assumption that "natural" equates to "safe" is a dangerous fallacy.
Regulatory Gray Zones
Unlike FDA-approved pharmaceuticals, kratom is largely unregulated in the United States. This leads to massive inconsistencies in potency, purity, and labeling. A consumer buying a packet of kratom at a local smoke shop has no guarantee of the alkaloid content, nor can they be sure it is free from contaminants.
The Hidden Risks of Polysubstance Use
From a clinical perspective, the most alarming trend is the "stacking" of substances. I frequently encounter patients who are using kratom in combination with alcohol, benzodiazepines, or even opioids.
- The Respiratory Risk: Combining kratom with other sedating agents can trigger dangerous respiratory depression—a risk that is rarely discussed in the marketing of "natural" herbal supplements.
- Physical Dependence: While kratom users often tout its benefits for energy and mood, the reality is that the body eventually adapts. Withdrawal from long-term kratom use can be as taxing as withdrawal from more traditional opioids, characterized by severe anxiety, muscle aches, and sleep disturbances, which ironically leads many users back to the substance to quell the very symptoms it created.
Implications: Whose Discomfort Are We Treating?
The most critical question for clinicians today is: Whose discomfort are we treating?
When a woman comes into a clinic in a state of high distress, it is tempting to reach for the prescription pad or suggest a supplement to provide immediate relief. But if we treat the symptom without addressing the underlying stressors—the lack of structural support, the hormonal shifts of midlife, the societal expectations of constant productivity—we are not healing; we are merely suppressing the evidence of a life that is currently unmanageable.
Reimagining the Treatment Plan
- Patience and Curiosity: Clinicians must move away from the "fix-it" mindset. We need to normalize asking, "What is happening in your life right now?" before we ask, "What medication can I give you?"
- Addressing the "Midlife Gap": We need better, more nuanced medical care for women in midlife that addresses hormonal health as a cornerstone of mental health, rather than a separate, secondary concern.
- Education on Substance Interactions: The medical community must be proactive in discussing the dangers of herbal supplements like kratom. We cannot assume that because a patient is "health-conscious" enough to avoid big pharma, they are not at risk for severe, substance-related harm.
The Path Forward
We must offer women more than a binary choice: either endure the agonizing symptoms of anxiety and burnout, or rely on a substance—whether it be a doctor-prescribed sedative or an unregulated herbal product—to mask them indefinitely.
True progress requires us to validate women’s distress without treating them as if they are broken. It requires us to listen to the stories behind the symptoms. For many, that story began years ago with a genuine need for help, a well-meaning provider, and a system that prioritized quick relief over long-term wellness.
As we continue to navigate the complexities of kratom and other emerging substances, we must remember that behind every statistic is a person trying to keep their head above water. It is time we stop handing them a "little helper" and start building a support system that actually addresses the weight they are carrying.
